11.10.2013 Views

production of selected secondary metabolites in transformed ...

production of selected secondary metabolites in transformed ...

production of selected secondary metabolites in transformed ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Determ<strong>in</strong>ation <strong>of</strong> fatty acids<br />

A simplified method for analysis <strong>of</strong> fatty acids <strong>in</strong> human serum was used accord<strong>in</strong>g to<br />

Kang at al. 2005 (4). Fatty acids were methylated us<strong>in</strong>g BF3/methanol reagent and extracted<br />

to hexane phase. Fatty acids methyl esters were measured us<strong>in</strong>g GC-FID method. In each<br />

sample 30 different fatty acids were detected us<strong>in</strong>g external standards.<br />

RESULTS<br />

After 3-month <strong>in</strong>take OF PUFA/tocopherol supplemet a significant decrease <strong>of</strong> serum<br />

cholesterol, LDL-cholesterol (10-15%) and ma<strong>in</strong>ly triglycerides (about 35%) <strong>in</strong><br />

hyperlipidaemic patients was observed. No similar changes <strong>in</strong> controls was shown. While the<br />

decrease <strong>of</strong> cholesterol as well as LDL-cholesterol levels was caused predom<strong>in</strong>antly by<br />

tocopherol effect, TAG levels could be <strong>in</strong>fluenced by comb<strong>in</strong>ed effect <strong>of</strong> PUFA and<br />

tocopherol. Further, PUFA/tocopherol <strong>in</strong>take led to a significant <strong>in</strong>crease <strong>of</strong> tocopherol levels<br />

and TAS and, thus, to correspond<strong>in</strong>g decrease <strong>of</strong> serum AGEs and AOPPs.<br />

The pr<strong>of</strong>iles <strong>of</strong> serum fatty acids (FA) shown also some changes after supplementation. A<br />

significant decrease <strong>of</strong> saturated FA (myristic, palmitic, stearic acid) was observed <strong>in</strong> all<br />

groups. Different changes <strong>of</strong> unsaturated FA were observed <strong>in</strong> hyperlipidaemics when<br />

compared with controls. A significant <strong>in</strong>crease <strong>of</strong> PUFA mixture, EPA and DHA was found<br />

<strong>in</strong> controls, while no changes <strong>of</strong> PUFA, EPA and moderate changes <strong>of</strong> DHA were observed<br />

<strong>in</strong> hyperlipidaemics.<br />

The ma<strong>in</strong> problem with any epidemiological study is that correlation does not imply<br />

causation. There are many other factors, that could be responsible for biological effect.<br />

Additional problems are connected with group composition as well as with biomarker<br />

selection (1). Moreover, <strong>in</strong> Czech population basal levels <strong>of</strong> antioxidants were chang<strong>in</strong>g <strong>in</strong><br />

the course <strong>of</strong> time.<br />

Despite these problems, our results <strong>in</strong>dicated, that <strong>in</strong>take <strong>of</strong> food supplement conta<strong>in</strong><strong>in</strong>g<br />

PUFA and tocopherol can positively <strong>in</strong>fluence lipid metabolism and antioxidant status <strong>in</strong><br />

patients with hyperlipidaemia. Very important is composition <strong>of</strong> vitam<strong>in</strong> preparative; many<br />

commercial PUFA are extensively oxidized and, thus, isoprostan formation can occur.<br />

Acknowledgements: This work was supported by project FRVS 3150/G1/2006 the Czech<br />

M<strong>in</strong>istry <strong>of</strong> Education, Youth and Sport.<br />

References:<br />

1. Halliwell B., Gutterdige J.M.C.: Free Radicals <strong>in</strong> Biology and Medic<strong>in</strong>e. 3rd Edition,<br />

Oxford University Press, 1999<br />

2. Witko-Sarsat et al.: Advanced Oxidation Prote<strong>in</strong> Products as Novel Mediators <strong>of</strong><br />

Inflammation and Monocyte Activation <strong>in</strong> Chronic Renal Failure. The Journal <strong>of</strong><br />

Immunology 2524-2532, 1998<br />

3. Kalousová M. et al.: Advanced Glycation End-Products and Advanced Oxidation<br />

Prote<strong>in</strong> Products <strong>in</strong> Patients with Diabetes Mellitus. Physiol. Res. 51: 597-604, 2002<br />

4. Kang J.X., Wang J.: A simplified method for analysis <strong>of</strong> polyunsaturated fatty acids.<br />

BMC Biochemistry 6:5, 2005<br />

Sborník soutěže Studentské tvůrčí č<strong>in</strong>nosti Student 2006 a doktorské soutěže O cenu děkana 2005 a 2006<br />

Sekce DSP 2006, strana 212

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!